NCT00527332

Brief Summary

The purpose of this study is to determine whether spinal anesthesia combined with intrathecal morphine in abdominal hysterectomy on benign gynecological indications gives better outcome concerning duration of hospital stay and postoperative patient comfort than general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Mar 2007

Typical duration for phase_4

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 10, 2007

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

December 21, 2011

Completed
Last Updated

January 26, 2012

Status Verified

January 1, 2012

Enrollment Period

2.3 years

First QC Date

September 7, 2007

Results QC Date

November 14, 2011

Last Update Submit

January 24, 2012

Conditions

Keywords

HospitalizationPostoperative careQuality of LifeHealth economyAnesthesia. SpinalAnesthesia, General

Outcome Measures

Primary Outcomes (1)

  • Duration of Hospital Stay.

    Duration of hospital stay defined as time from start anesthesia to leaving the hospital

    Within 6 months after surgery

Secondary Outcomes (7)

  • Occurrence and Degree of Postoperative Symptoms.

    Within 6 months after the surgery

  • Postoperative Consumption of Analgesics and Antiemetics.

    Within 6 months after surgery

  • Complications and Complication Rates.

    Within 6 months after the surgery

  • Quality of Life and QALYs (Quality Adjusted Life Years).

    Within 6 months after the surgery

  • Sick Leave.

    Within 6 months after the surgery

  • +2 more secondary outcomes

Study Arms (2)

A

ACTIVE COMPARATOR

Spinal anesthesia combined with intrathecal morphine. Spinal anesthesia applied in intervertebral space L3/L4 or L2/L3 with hyperbaric bupivacaine 20 mg and morphine 0.2 mg intrathecally. Sedation with propofol.

Drug: BupivacainDrug: MorphineDrug: Propofol

B

ACTIVE COMPARATOR

General anesthesia. General anesthesia induced with propofol, fentanyl and rocuronium, and maintained with propofol and oxygen in air. Rocuronium and fentanyl repeated when needed.

Drug: PropofolDrug: FentanylDrug: RocuronbromidDrug: Morphine

Interventions

5 mg/mL, 4 mL intrathecally as a single dos

Also known as: Marcain spinal tung., ATC-code: N01BB01
A

0.4 mg/mL; 0.5 mL intrathecally as a single dosage

Also known as: Morfin Special, ATC-code: N02AA01
A

2-5 mg/kg body weight/hours IV (intravenously) for sedation during the surgery

Also known as: ATC-code: N01AX10
A

100-200 microgram IV (intravenously) at start of anesthesia. 50-100 microgram IV on demand during surgery.

Also known as: ATC-code:N01AH01
B

0.6 mg/kg body weight IV (intravenously) at induction of anesthesia. If additional muscle relaxation is needed during surgery 5-10 mg is injected IV. The drug is given only at induction of anesthesia and during surgery

Also known as: Esmeron, ATC-code: M03AC09
B

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female between 18 and 60 years of age.
  • Scheduled for abdominal hysterectomy - total or subtotal -on benign gynecological indication.
  • At least one ovary planned to be preserved at the hysterectomy.
  • Can understand and communicate in Swedish
  • Accept participation after written and verbal information and after signed informed consent.
  • Has supervision at home after discharge from hospital during the first couple of days and has access to a telephone.

You may not qualify if:

  • Contra-indications against spinal or general anesthesia or the standard dosage of the study drugs
  • ASA classification ≥ Class 3
  • Postmenopausal women without HRT (hormone replacement therapy).
  • Suspected gynecological malignancy
  • Previously undergone bilateral oophorectomy
  • Substantial physically disabled so that a normal recovery with early physical mobilization can not be anticipated.
  • Mentally or severly psychic disabled

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Eksjö Hospital

Eksjö, 57581, Sweden

Location

Ryhov Hospital

Jönköping, 55185, Sweden

Location

University Hospital

Linköping, 58185, Sweden

Location

Vrinnevi Hospital

Norrköping, 60182, Sweden

Location

Värnamo Hospital

Värnamo, 33185, Sweden

Location

Related Publications (8)

  • Vårdtid, funktionskapacitet och sjukskrivningstider efter hysterektomi. Nationella data från 6503 patienter opererade år 2000 och 2001. Återrapport från Nationella registret för kvalitetsutveckling inom gynekologisk kirurgi (Gynop-registret), SFOG, 2003.

    BACKGROUND
  • Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002 Jun;183(6):630-41. doi: 10.1016/s0002-9610(02)00866-8.

    PMID: 12095591BACKGROUND
  • Wilmore DW, Kehlet H. Management of patients in fast track surgery. BMJ. 2001 Feb 24;322(7284):473-6. doi: 10.1136/bmj.322.7284.473. No abstract available.

    PMID: 11222424BACKGROUND
  • Moller C, Kehlet H, Friland SG, Schouenborg LO, Lund C, Ottesen B. Fast track hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2001 Sep;98(1):18-22. doi: 10.1016/s0301-2115(01)00342-6.

    PMID: 11516794BACKGROUND
  • Persson P, Wijma K, Hammar M, Kjolhede P. Psychological wellbeing after laparoscopic and abdominal hysterectomy--a randomised controlled multicentre study. BJOG. 2006 Sep;113(9):1023-30. doi: 10.1111/j.1471-0528.2006.01025.x.

    PMID: 16956334BACKGROUND
  • Ellstrom MA, Astrom M, Moller A, Olsson JH, Hahlin M. A randomized trial comparing changes in psychological well-being and sexuality after laparoscopic and abdominal hysterectomy. Acta Obstet Gynecol Scand. 2003 Sep;82(9):871-5. doi: 10.1080/j.1600-0412.2003.00216.x.

    PMID: 12911451BACKGROUND
  • Kjolhede P, Langstrom P, Nilsson P, Wodlin NB, Nilsson L. The impact of quality of sleep on recovery from fast-track abdominal hysterectomy. J Clin Sleep Med. 2012 Aug 15;8(4):395-402. doi: 10.5664/jcsm.2032.

  • Kjolhede P, Borendal Wodlin N, Nilsson L, Fredrikson M, Wijma K. Impact of stress coping capacity on recovery from abdominal hysterectomy in a fast-track programme: a prospective longitudinal study. BJOG. 2012 Jul;119(8):998-1006; discussion 1006-7. doi: 10.1111/j.1471-0528.2012.03342.x. Epub 2012 May 9.

MeSH Terms

Interventions

BupivacaineMorphinePropofolFentanylRocuronium

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsPiperidinesHeterocyclic Compounds, 1-RingAndrostanolsAndrostanesSteroidsFused-Ring Compounds

Results Point of Contact

Title
Dr Preben Kjolhede
Organization
Deptartment of Obstetrics and Gynecology, University Hospital, Linköping, Sweden

Study Officials

  • Preben Kjölhede, MD, PhD

    Department of Obstetrics and Gynecology, University Hospital, Linköping

    STUDY CHAIR
  • Lena Nilsson, MD, PhD

    Department of Anesthesiology, University Hospital, Linköping

    STUDY DIRECTOR
  • Ninnie B. Wodlin, MD

    Department of Obstetrics and Gynecology, University Hospital, Linköping

    STUDY DIRECTOR
  • Kenneth Krohn, MD

    Department of Ostetrics and Gynecology, Vrinnevi Hospital, Norrköping

    PRINCIPAL INVESTIGATOR
  • Lars Nordenberg, MD

    Department of Anesthesiology, Vrinnevi Hospital, Norrköping

    PRINCIPAL INVESTIGATOR
  • Mats D. Karlsson, MD

    Department of Obstetrics and Gynecology, Ryhov Hospital, Jönköping

    PRINCIPAL INVESTIGATOR
  • Veronica Annerhagen, MD

    Department of Anesthesiology, Ryhov Hospital, Jönköping

    PRINCIPAL INVESTIGATOR
  • Christina Gunnervik, MD

    Department of Obstetrics and Gynecology, Värnamo Hospital

    PRINCIPAL INVESTIGATOR
  • Magnus Trofast, MD

    Department of Anesthesiology, Värnamo Hospital

    PRINCIPAL INVESTIGATOR
  • Tomasz Stypa, MD

    Department of Obstetrics and Gynecology, Eksjö Hospital

    PRINCIPAL INVESTIGATOR
  • Albert Sundberg, MD, PhD

    Department of Anesthesiology, Eksjö Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

September 7, 2007

First Posted

September 10, 2007

Study Start

March 1, 2007

Primary Completion

June 1, 2009

Study Completion

December 1, 2009

Last Updated

January 26, 2012

Results First Posted

December 21, 2011

Record last verified: 2012-01

Locations